{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:01:16Z","timestamp":1760014876131},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T00:00:00Z","timestamp":1202860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aciclovir prophylaxis was previously given to all immunocompromised patients treated by our unit, following contact with varicella zoster. In 2003, we changed practice according to National Guidelines, giving prophylaxis only to patients without serum varicella zoster immunoglobulin G antibody (VZ IgG) at diagnosis of their malignancy. Since then we have seen nine patients with acute lymphoblastic leukaemia (ALL) and VZ IgG positivity at diagnosis of their malignancy develop chickenpox. Our observations question current practice for patients with ALL. Pediatr Blood Cancer 2008;51:540\u2013542. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/pbc.21521","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T17:47:33Z","timestamp":1202924853000},"page":"540-542","source":"Crossref","is-referenced-by-count":14,"title":["Chickenpox in varicella IgG positive patients: Experience of a regional paediatric oncology centre"],"prefix":"10.1002","volume":"51","author":[{"given":"Sue","family":"Manley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Mallinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Caswell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Pizer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,2,13]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"Royal College of Paediatrics and Child Health.Immunisation of the immunocompromised child. Best practice statement2002."},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1542\/peds.56.3.388","article-title":"Varicella in children with cancer: Seventy\u2010seven cases","volume":"56","author":"Feldman S","year":"1975","journal-title":"Pediatrics"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.80.4.465"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.2.309"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05509.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.92.2.223","article-title":"Severe varicella associated with steroid use","volume":"92","author":"Dowell SF","year":"1993","journal-title":"Pediatrics"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1542\/peds.92.2.288","article-title":"Steroids and varicella","volume":"92","author":"Reiches N","year":"1993","journal-title":"Pediatrics"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199010000-00009"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0219"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.78.4.757"},{"key":"e_1_2_6_12_2","first-page":"166","article-title":"Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunisation of their siblings","volume":"87","author":"Diaz PS","year":"1991","journal-title":"Pediatrics"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.1999.00382.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2003.09.006"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/08880019609030821"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.85.2.83"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2004.00216.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60567-4"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2007.123232"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705397"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21521","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21521","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.21521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T15:47:28Z","timestamp":1697644048000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.21521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,13]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1002\/pbc.21521"],"URL":"https:\/\/doi.org\/10.1002\/pbc.21521","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,13]]}}}